Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06827795 · ClinicalTrials.gov registry record · NA

An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)

A NA study of Spine Surgery, sponsored by Surgify Medical Oy.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT06827795: Recruiting NA study of Spine Surgery, sponsored by Surgify Medical Oy.

NCT06827795 is a NA study of Spine Surgery that is actively recruiting participants, run by Surgify Medical Oy. The registered enrollment target is 30 participants, below the 283-participant average among 6 other Spine Surgery trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06827795, a NA study of Spine Surgery, is actively recruiting participants, sponsored by Surgify Medical Oy.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

The purpose of this research study is to: test the usability and performance of the medical device Surgify Halo ™ in revision spine surgery test the level of "chattering " during the use of the device test the cutting performance of Surgify Halo™in comparison to the usual drill bit used in spine surgery ( Rosen burr). This medical device is available for its indications for shaping and removal of hard tissue and bone in neurosurgical, spinal, ENT, and general surgical procedures. The target is to enroll 30 participants in this study.

Primary Outcome

Test the level of "chattering " during the use of the device and test the cutting performance of Surgify Halo™ in comparison to the usual drill bit used in spine surgery ( Rosen burr)

Conditions Studied

Interventions

  • DEVICE A burr used in spine surgery

Study Locations (1)

New York

  • North Shore University Hospital - New York

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-02-19
Est. Completion 2026-12-31
Phase NA
Surgify Medical Oy

1 total trials

What NCT06827795 shows while recruiting

NCT06827795 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 30 participants, a relatively small participant target, below the 283-participant average among 6 other Spine Surgery trials with a reported enrollment target (89% lower).

The record links to 1 condition, with Spine Surgery appearing as the primary indexed condition, and to 1 intervention - of which A burr used in spine surgery is the first listed.

NCT06827795 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT06827795 about?

NCT06827795 is a clinical study titled "An Open, Parallel-group, Randomized, Medical Device Study to Assess the Usability and Performance of Surgify HaloTM in Spine Surgery Versus State-of-art (Rosen Burr)". The purpose of this research study is to: test the usability and performance of the medical device Surgify Halo ™ in revision spine surgery test the level of "chattering " during the use of the device test the cutting performance of Surgify Halo™in comparison to the usual drill bit used in spine su...

What is the current status of trial NCT06827795?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-02-19. Estimated completion is 2026-12-31.

What conditions does trial NCT06827795 study?

This clinical trial studies the following conditions: Spine Surgery.

What interventions are being tested in trial NCT06827795?

The interventions under investigation include: A burr used in spine surgery (DEVICE).

Who is sponsoring clinical trial NCT06827795?

This trial is sponsored by Surgify Medical Oy, which has 1 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06827795 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spine Surgery

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00977977 · 30 participants · Phase 2

    Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy

  • NCT01459107 · 30 participants · Phase 2

    Human Upper Extremity Allotransplantation

  • NCT01666080 · 30 participants · NA

    Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)

  • NCT01720836 · 30 participants · Phase 1

    Study of the Immune Response of MUC1 (Mucin1) Peptide Vaccine for Non-small Cell Lung Cancer

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06827795, the US trial registry maintained by the National Library of Medicine. NCT06827795 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.